Characterization of the melatoninergic MT3 binding site on the NRH:quinone oxidoreductase 2 enzyme.
Mailliet F, Ferry G, Vella F, Berger S, Cogé F, Chomarat P, Mallet C, Guénin SP, Guillaumet G, Viaud-Massuard MC, Yous S, Delagrange P, Boutin JA.
Mailliet F, et al. Among authors: coge f.
Biochem Pharmacol. 2005 Dec 19;71(1-2):74-88. doi: 10.1016/j.bcp.2005.09.030. Epub 2005 Nov 15.
Biochem Pharmacol. 2005.
PMID: 16293234